rs148891181
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033305.3(VPS13A):c.4390C>A(p.His1464Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000282 in 1,612,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033305.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.4390C>A | p.His1464Asn | missense_variant | 37/72 | ENST00000360280.8 | NP_150648.2 | |
VPS13A | NM_001018037.2 | c.4273C>A | p.His1425Asn | missense_variant | 36/71 | NP_001018047.1 | ||
VPS13A | NM_015186.4 | c.4390C>A | p.His1464Asn | missense_variant | 37/69 | NP_056001.1 | ||
VPS13A | NM_001018038.3 | c.4390C>A | p.His1464Asn | missense_variant | 37/69 | NP_001018048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13A | ENST00000360280.8 | c.4390C>A | p.His1464Asn | missense_variant | 37/72 | 1 | NM_033305.3 | ENSP00000353422.3 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000216 AC: 54AN: 249554Hom.: 0 AF XY: 0.000222 AC XY: 30AN XY: 135192
GnomAD4 exome AF: 0.000284 AC: 415AN: 1460220Hom.: 0 Cov.: 31 AF XY: 0.000282 AC XY: 205AN XY: 726502
GnomAD4 genome AF: 0.000263 AC: 40AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74402
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | VPS13A: PM2, BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 04, 2022 | This sequence change replaces histidine, which is basic and polar, with asparagine, which is neutral and polar, at codon 1464 of the VPS13A protein (p.His1464Asn). This variant is present in population databases (rs148891181, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with VPS13A-related conditions. ClinVar contains an entry for this variant (Variation ID: 367382). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 20, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.4390C>A (p.H1464N) alteration is located in exon 37 (coding exon 37) of the VPS13A gene. This alteration results from a C to A substitution at nucleotide position 4390, causing the histidine (H) at amino acid position 1464 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Chorea-acanthocytosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at